المؤلفون: Jarcy Zee, Daniel Muenz, Keith P. McCullough, Brian Bieber, Marie Metzger, Natalia Alencar de Pinho, Antonio A. Lopes, Danilo Fliser, Bruce M. Robinson, Eric Young, Ronald L. Pisoni, Bénédicte Stengel, Roberto Pecoits-Filho, Christian Combe, MD, Johannes Duttlinger, MD, Danilo Fliser, MD, Christian Jacquelinet, MD, Gerhard Lonnemann, MD, Antonio Lopes, MD, MPH, PhD, Ziad Massy, MD, PhD, Roberto Pecoits-Filho, MD, Helmut Reichel, MD, Bénédicte Stengel, MD, PhD, Takashi Wada, MD, Kunihiro Yamagata, MD

المصدر: Kidney Medicine, Vol 4, Iss 2, Pp 100395- (2022)

مصطلحات موضوعية: Chronic kidney disease progression, composite outcomes, estimated glomerular filtration rate, kidney failure, surrogate end points, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2590059521002533Test; https://doaj.org/toc/2590-0595Test

الوصول الحر: https://doaj.org/article/2abda2bf9c8b474f899c00d099e47e9cTest

المؤلفون: Albert Tang

المصدر: Current Therapeutic Research, Vol 97, Iss , Pp 100680- (2022)

مصطلحات موضوعية: Clinical trials, Dose analysis, Drug approval, Surrogate end points, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S0011393X22000194Test; https://doaj.org/toc/0011-393XTest

الوصول الحر: https://doaj.org/article/55d409378cf04cbf8124d69f307de3adTest

المؤلفون: Ma, Christopher, Schoepfer, Alain M., Dellon, Evan S., Bredenoord, Albert J., Chehade, Mirna, Collins, Margaret H., Feagan, Brian G., Furuta, Glenn T., Gupta, Sandeep K., Hirano, Ikuo, Jairath, Vipul, Katzka, David A., Pai, Rish K., Rothenberg, Marc E., Straumann, Alex, Aceves, Seema S., Alexander, Jeffrey A., Arva, Nicoleta C., Atkins, Dan, Biedermann, Luc, Blanchard, C, Cianferoni, A, Ciriza de Los Rios, C, Clayton, F, Davis, CM, de Bortoli, N, Dias, JA, Falk, GW, Genta, RM, Ghaffari, G, Gonsalves, N, Greuter, T, Hopp, R, Hsu Blatman, KS, Jensen, ET, Johnston, D, Kagalwalla, AF, Larsson, HM, Leung, J, Louis, H, Masterson, JC, Menard-Katcher, C, Menard-Katcher, PA, Moawad, FJ, Muir, AB, Mukkada, VA, Penagini, R, Pesek, RD, Peterson, K, Putnam, PE, Ravelli, A, Savarino, EV, Schlag, C, Schreiner, P, Simon, D, Smyrk, TC, Spergel, JM, Taft, TH, Terreehorst, I, Vanuytsel, T, Venter, C, Vieira, MC, Vieth, M, Vlieg-Boerstra, B, von Arnim, U, Walker, Marjorie M., Wechsler, JB, Woodland, P, Woosley, JT, Yang, Guang-Yu, Zevit, N, Safroneeva, E

المساهمون: The University of Newcastle. College of Health, Medicine & Wellbeing, School of Medicine and Public Health

مصطلحات موضوعية: eosinophilic esophagitis, outcomes, clincial trials, end points, histology, histopathology

العلاقة: Journal of Allergy and Clinical Immunology Vol. 149, Issue 2, p. 659-670; http://hdl.handle.net/1959.13/1453914Test; uon:44768

الإتاحة: http://hdl.handle.net/1959.13/1453914Test

المؤلفون: Jay M. Lee, MD, Anthony W. Kim, MD, Tomasz Marjanski, MD, PhD, Pierre-Emmanuel Falcoz, MD, PhD, Masahiro Tsuboi, MD, PhD, Yi-Long Wu, MD, Shawn W. Sun, PharmD, Barbara J. Gitlitz, MD

المصدر: JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100221- (2021)

مصطلحات موضوعية: Early stage, Lung cancer, Neoadjuvant PD-L1 inhibitor therapy, Surgical end points, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364321000801Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/fba21396acdf4e6fa8789e3a680a3b71Test

المؤلفون: Shafieiyoun, Saeid, Thomson, Neil R., Brey, Andrew P., Gasinski, Chris M., Pence, William, Marley, Mike

مصطلحات موضوعية: Coal tar, Long-term expectations, Mass transfer, MGP, Permanganate, Persulfate, Treatment end-points

العلاقة: https://dx.doi.org/10.1016/j.jconhyd.2018.08.007Test; http://hdl.handle.net/10012/14189Test

الإتاحة: https://doi.org/10.1016/j.jconhyd.2018.08.007Test
http://hdl.handle.net/10012/14189Test

المؤلفون: Liu, J, Lichtenberg, T, Hoadley, KA, Poisson, LM, Lazar, AJ, Cherniack, AD, Kovatich, AJ, Benz, CC, Levine, DA, Lee, AV, Omberg, L, Wolf, DM, Shriver, CD, Thorsson, V, Hu, H

المساهمون: SAIC-F-Frederick, Inc, Leidos Biomedical Research, Inc.

المصدر: 416.e11 ; 400

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Biochemistry & Molecular Biology, Cell Biology, COMPREHENSIVE GENOMIC CHARACTERIZATION, PROGRESSION-FREE SURVIVAL, SUFFICIENT FOLLOW-UP, BREAST-CANCER, END-POINTS, MOLECULAR PORTRAITS, TIME, CLASSIFICATION, DEFINITIONS, RECURRENCE, Cox proportional hazards regression model, TCGA, The Cancer Genome Atlas, clinical data resource, disease-free interval, disease-specific survival, follow-up time, overall survival, progression-free interval, translational research, Databases, Genetic, Genomics, Humans, Kaplan-Meier Estimate, Neoplasms

العلاقة: Cell; http://hdl.handle.net/10044/1/71224Test; https://doi.org/10.1016/j.cell.2018.02.052Test; TCGA Pilot Program; 15Y011ST

الإتاحة: https://doi.org/10.1016/j.cell.2018.02.052Test
http://hdl.handle.net/10044/1/71224Test

المؤلفون: Bomback, Andrew, Appel, Gerald, Gipson, Debbie, Hladunewich, Michelle, Lafayette, Richard, Nester, Carla, Parikh, Samir, Smith, Richard, Trachtman, Howard, Heeger, Peter, Ram, Sanjay, Rovin, Brad, Ali, Shadab, Arceneaux, Nicole, Ashoor, Isa, Bailey-Wickins, Laura, Barratt, Jonathan, Beck, Laurence, Cattran, Daniel, Cravedi, Paolo, Erkan, Elif, Fervenza, Fernando, Frazer-Abel, Ashley, Fremeaux-Bacchi, Veronique, Fuller, Lindsey, Gbadegesin, Rasheed, Hogan, Jonathan, Kiryluk, Krzysztof, Le Quintrec-Donnette, Moglie, Licht, Christoph, Mahan, John, Pickering, Matthew, Quigg, Richard, Rheault, Michelle, Ronco, Pierre, Sarwal, Minnie, Sethna, Christine, Spino, Cathie, Stegall, Mark, Vivarelli, Marina, Feldman, David, Thurman, Joshua

المساهمون: Columbia University Irving Medical Center (CUIMC), New York University Langone Medical Center (NYU Langone Medical Center), NYU System (NYU), University of Michigan Medical School Ann Arbor, University of Michigan Ann Arbor, University of Michigan System-University of Michigan System, Sunnybrook Health Sciences Centre Toronto (Sunnybrook), Stanford School of Medicine Stanford, Stanford Medicine, Stanford University-Stanford University, University of Iowa Iowa City, College of Medicine and Public Health Colombus, Icahn School of Medicine at Mount Sinai New York (MSSM), University of Massachusetts Medical School Worcester (UMASS), University of Massachusetts System (UMASS), Ohio State University Columbus (OSU), National Kidney Foundation (NKF), Louisiana State University (LSU), University of Leicester, Boston University School of Medicine (BUSM), Boston University Boston (BU), University of Toronto, Cincinnati Children's Hospital Medical Center, Mayo Clinic Rochester, University of Colorado Anschutz Aurora, Service de Néphrologie et Hémodialyse CHU HEGP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Duke University Durham, Hospital of the University of Pennsylvania (HUP), Perelman School of Medicine, University of Pennsylvania-University of Pennsylvania, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Imperial College London, University of Minnesota Medical School, University of Minnesota System (UMN), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), University of California San Francisco (UC San Francisco), University of California (UC), Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University Hempstead, IRCCS Ospedale Pediatrico Bambino Gesù = Bambino Gesù Children’s Hospital

المصدر: ISSN: 0272-6386.

مصطلحات موضوعية: Glomerular disease, Clinical trial design, Complement biomarkers, Complement blockade, Complement inhibition, Complement-mediated glomerulopathy, Drug approval pathway, Drug safety, Glomerulonephritides, Infectious risk, Patient-reported outcome (PRO), Rare diseases, Research priorities, Surrogate outcome, Trial end points, MESH: Complement Inactivator Proteins, MESH: Complement System Proteins, MESH: Humans, MESH: Kidney, MESH: Kidney Diseases, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34571062; hal-03648369; https://hal.umontpellier.fr/hal-03648369Test; PUBMED: 34571062

الإتاحة: https://doi.org/10.1053/j.ajkd.2021.07.025Test
https://hal.umontpellier.fr/hal-03648369Test

المؤلفون: Eulenburg, C, Wegscheider, K, Woehrle, H, Angermann, C, D'Ortho, MP, Erdmann, E, Levy, P, Simonds, AK, Somers, VK, Zannad, F, Teschler, H, Cowie, MR

المساهمون: Imperial College Trust, Royal Brompton & Harefield NHS Foundation Trust, ResMed Ltd

المصدر: 881 ; 873

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Critical Care Medicine, Respiratory System, General & Internal Medicine, CENTRAL SLEEP-APNEA, CHEYNE-STOKES RESPIRATION, COMPOSITE END-POINTS, VENTILATION, TRIALS, Aged, Cause of Death, Death, Sudden, Cardiac, Female, Heart Failure, Hospitalization, Humans, Interactive Ventilatory Support, Male, Middle Aged, Proportional Hazards Models, Sleep Apnea, Central, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Ventricular Function

العلاقة: The Lancet Respiratory Medicine; http://hdl.handle.net/10044/1/43404Test; N/A; 6059; L02.010.062

الإتاحة: https://doi.org/10.1016/S2213-2600Test(16)30244-2
http://hdl.handle.net/10044/1/43404Test

المؤلفون: Ampuero, Javier, Romero-Gomez, Manuel

المساهمون: [Ampuero, Javier] Hosp Univ Virgen del Rocio, Seville, Spain, [Romero-Gomez, Manuel] Hosp Univ Virgen del Rocio, Seville, Spain, [Ampuero, Javier] Inst Biomed Sevilla, SeLiver Grp, Seville, Spain, [Romero-Gomez, Manuel] Inst Biomed Sevilla, SeLiver Grp, Seville, Spain, [Ampuero, Javier] CIBERehd, Madrid, Spain, [Romero-Gomez, Manuel] CIBERehd, Madrid, Spain, Consejeria de Salud de la Junta de Andalucia, Spanish Ministry of Economy, Innovation and Competition, Instituto de Salud Carlos III

مصطلحات موضوعية: Clinical trial, NAFLD, End-points, Definitions, Stratification, Nonalcoholic steatohepatitis, Alcohol, Lifestyle, Placebo, Comorbidities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2636::ed21f0ec053dfddc541cea7a5152ec6eTest
https://hdl.handle.net/10668/18825Test

المؤلفون: Rial, Diego, Murado García, Miguel Anxo, Menduiña, Araceli, Fuciños, P., González Fernández, Pilar, Mirón, Jesús, Vázquez, José Antonio

مصطلحات موضوعية: Spill-treating agents, Weibull and logistic equations, Algae growth kinetics, EC50, Toxicological end-points

العلاقة: http://dx.doi.org/10.1016/j.jhazmat.2013.07.010Test; Journal of Hazardous Materials 263(P2): 374-381 (2013); http://hdl.handle.net/10261/80507Test

الإتاحة: https://doi.org/10.1016/j.jhazmat.2013.07.010Test
http://hdl.handle.net/10261/80507Test